Gelteq is trading at $0.46, down 5.71%, with no confirmed company-specific catalyst for the November 4 decline.
- On November 2, Gelteq said it needed additional time to complete its annual report and expected to file within the permitted 15-day grace period. The notice included no preliminary financial figures, and available evidence does not establish that it caused the decline.
- Major U.S. indexes were rising in the supplied market context, so broad-market weakness does not explain the decline.